Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Braca Insider Profile
4 Followers
John Braca, See Remarks at Eloxx Pharmaceuticals, holds 15.02K shares in US Gold (Ticker: USAU), holds 137.96K shares in Eloxx Pharmaceuticals (Ticker: ELOX).
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-43.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Braca holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 16, 2009 - Mar 16, 2010
Return:-29.40%
The most profitable trade made by John Braca
John Braca's Trading History
Eloxx Pharmaceuticals
May 27, 2010
See Remarks
Uninformative Buy
2.01K
$126.38K
US Gold
Nov 04, 2020
Director
Uninformative Buy
―
$63.81K
List of latest transactions for each holding click on a transaction to see John Braca's performance on stock
You May Also Like
John Braca insider profile FAQ
What is the percentage of profitable transactions made by John Braca?
The percentage of profitable transactions made by John Braca is 0%.
What is the average return per transaction made by John Braca?
The average return per transaction made by John Braca is -43.50%.
What stocks does John Braca hold?
John Braca holds: ELOX, USAU stocks.
What was John Braca’s latest transaction?
John Braca latest transaction was an Uninformative Buy of ―.
What was John Braca's most profitable transaction?
John Braca’s most profitable transaction was an Informative Buy of ELOX stock on March 16, 2009. The return on the trade was -29.40%.
What is John Braca's role in Eloxx Pharmaceuticals?
John Braca's role in Eloxx Pharmaceuticals is See Remarks.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.